CEFOTAXIME/CLAVULANIC, 30/10UG, BBL SENSI-DISC AND CEFTAZIDIME/CLAVULANIC ACID, 30/10UG, BBL SENSI-DISC

Susceptibility Test Discs, Antimicrobial

BECTON DICKINSON MICROBIOLOGY SYSTEMS

The following data is part of a premarket notification filed by Becton Dickinson Microbiology Systems with the FDA for Cefotaxime/clavulanic, 30/10ug, Bbl Sensi-disc And Ceftazidime/clavulanic Acid, 30/10ug, Bbl Sensi-disc.

Pre-market Notification Details

• Device ID: K993577
• 510k Number: K993577
• Device Name: CEFOTAXIME/CLAVULANIC, 30/10UG, BBL SENSI-DISC AND CEFTAZIDIME/CLAVULANIC ACID, 30/10UG, BBL SENSI-DISC
• Classification: Susceptibility Test Discs, Antimicrobial
• Applicant: BECTON DICKINSON MICROBIOLOGY SYSTEMS 7 LOVETON CIR. Sparks, MD 21152 -0999
• Contact: Monica E Giguere
• Correspondent: Monica E Giguere; BECTON DICKINSON MICROBIOLOGY SYSTEMS 7 LOVETON CIR. Sparks, MD 21152 -0999
• Product Code: JTN
• CFR Regulation Number: 866.1620 [🔎]
• Decision: Substantially Equivalent (SESE)
• Type: Traditional
• 3rd Party Reviewed: No
• Combination Product: No
• Date Received: 1999-10-21
• Decision Date: 1999-12-01
• Summary: summary

NIH GUDID Devices

Device Identifier	submissionNumber	Supplement
00382902317531	K993577	000
00382902317517	K993577	000
30382902317549	K993577	000
30382902317525	K993577	000